Prediction of Future Weight Change With Dopamine Transporter
Sponsor
Pusan National University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03146429
Collaborator
(none)
200
3.4
Study Details
Study Description
Brief Summary
This is the re-analyzing study of observational study by Parkinson's Progression Markers Initiative
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
200 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Prediction of Future Weight Change With Dopamine Transporter
Study Start Date
:
Jan 1, 2017
Actual Primary Completion Date
:
Apr 15, 2017
Actual Study Completion Date
:
Apr 15, 2017
Outcome Measures
Primary Outcome Measures
- Weight change [1, 2, 3, 4, 5 year after SPECT]
weight change per year until 5 years after SPECT
Eligibility Criteria
Criteria
Ages Eligible for Study:
30 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- males or females with their age of 30 years or older at screening
Exclusion Criteria:
- subjects with a neurological disorder, a first degree relative with idiopathic PD, Montreal Cognitive Assessment score of 26 or less, medications that might interfere with DAT SPECT scans, anticoagulants that might preclude safe completion of the lumbar puncture, or investigational drugs, and a condition that precludes the safe performance of routine lumbar puncture
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Pusan National University Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Kyoungjune Pak,
Clinical Assistant Professor,
Pusan National University Hospital
ClinicalTrials.gov Identifier:
NCT03146429
Other Study ID Numbers:
- PusanNUH-2017
First Posted:
May 10, 2017
Last Update Posted:
Apr 24, 2018
Last Verified:
Apr 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: